This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
This year’s EFMC-ISMC conference in Nice, France, had a fantastic collection of talks. Among the highlights were the two First…
Article
1 year ago ●
6 mins read
Harnessing a novel mechanism for HIV eradication with a new class of bifunctional molecules. Modern antiretroviral therapies (ARTs) efficiently block…
molecule
6 months ago ●
5 mins read
Spinal Muscular Atrophy (SMA)—the leading genetic cause of childhood mortality—is a disease in which the gene SMN1 is deleted or…
Article
1 year ago ●
6 mins read
Preclinical validation for IRAK4 inhibitors for dermatology from activity in human biopsies. Interleukin-1 receptor-associated kinase (IRAK4) is downstream of toll-like…
molecule
6 months ago ●
5 mins read
An oral, brain penetrant EGFR mutant inhibitor with exquisite selectivity, a drug that was originally developed from a brain cholesterol…
Article
1 year ago ●
1 min read
Drug Hunter Reviewer Commentary. With over two decades of experience in neuroscience drug discovery, Drug Hunter reviewer Jake Schwarz says…
molecule
6 months ago ●
7 mins read
Load More
